Sylvie Deuffic-Burban
Sylvie Deuffic-Burban
Chercheur, Inserm
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Trends in primary liver cancer
S Deuffic, T Poynard, L Buffat, AJ Valleron
The Lancet 351 (9097), 214-215, 1998
3841998
Modeling the hepatitis C virus epidemic in France
S Deuffic, L Buffat, T Poynard, AJ Valleron
Hepatology 29 (5), 1596-1601, 1999
2691999
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study
Y Yazdanpanah, G De Carli, B Migueres, F Lot, M Campins, C Colombo, ...
Clinical Infectious Diseases 41 (10), 1423-1430, 2005
2422005
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States
S Deuffic‐Burban, T Poynard, MS Sulkowski, JB Wong
Journal of viral hepatitis 14 (2), 107-115, 2007
1942007
Blood-borne viruses in health care workers: prevention and management
S Deuffic-Burban, E Delarocque-Astagneau, D Abiteboul, E Bouvet, ...
Journal of Clinical Virology 52 (1), 4-10, 2011
1582011
Predicted effects of treatment for HCV infection vary among European countries
S Deuffic–Burban, P Deltenre, M Buti, T Stroffolini, J Parkes, ...
Gastroenterology 143 (4), 974-985. e14, 2012
1482012
Routine HIV screening in France: clinical impact and cost-effectiveness
Y Yazdanpanah, CE Sloan, C Charlois-Ou, S Le Vu, C Semaille, ...
PloS one 5 (10), e13132, 2010
1402010
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire
A Pasquet, E Messou, D Gabillard, A Minga, A Depoulosky, ...
PloS one 5 (10), e13414, 2010
1322010
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
F Zoulim, TJ Liang, AL Gerbes, A Aghemo, S Deuffic-Burban, G Dusheiko, ...
Gut 64 (11), 1824-1833, 2015
1242015
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections
S Deuffic-Burban, MK Mohamed, B Larouze, F Carrat, AJ Valleron
Journal of hepatology 44 (3), 455-461, 2006
1132006
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study
K Champenois, A Cousien, L Cuzin, S Le Vu, S Deuffic-Burban, E Lanoy, ...
BMC infectious diseases 13 (1), 1-10, 2013
1012013
Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial
JC Vaillant, B Nordlinger, S Deuffic, JP Arnaud, E Pelissier, JP Favre, ...
Annals of surgery 231 (4), 449, 2000
992000
Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe
S Deuffic, T Poynard, AJ Valleron
Journal of viral hepatitis 6 (5), 411-413, 1999
901999
Hepatitis C treatment as prevention of viral transmission and liver‐related morbidity in persons who inject drugs
A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, JS Dhersin, ...
Hepatology 63 (4), 1090-1101, 2016
862016
Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness
L Bocket, A Cheret, S Deuffic-Burban, P Choisy, Y Gerard, ...
Antivir Ther 10 (2), 247-54, 2005
842005
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model
S Deuffic‐Burban, T Poynard, AJ Valleron
Journal of viral hepatitis 9 (2), 114-122, 2002
842002
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference
A Hatzakis, P Van Damme, K Alcorn, C Gore, M Benazzouz, S Berkane, ...
Journal of viral hepatitis 20, 1-20, 2013
822013
Comparing the public health burden of chronic hepatitis C and HIV infection in France
S Deuffic-Burban, JB Wong, AJ Valleron, D Costagliola, JF Delfraissy, ...
Journal of hepatology 40 (2), 319-326, 2004
762004
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
S Deuffic-Burban, M Schwarzinger, D Obach, V Mallet, S Pol, ...
Journal of hepatology 61 (1), 7-14, 2014
712014
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d’Ivoire
E Losina, Y Yazdanpanah, S Deuffic-Burban, B Wang, LL Wolf, E Messou, ...
Antiviral therapy 12 (4), 543, 2007
702007
The system can't perform the operation now. Try again later.
Articles 1–20